Reference health
Fighting Neglected Diseases: A Double Push-and-Pull Program
1 of 46 checkable references need attention · checked 2026-08-27
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
32 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1787/clp-v4-art10-en
The 45 checked references that resolve
resolves10.1093/jiel/1.4.607
First Report (final) to the Committee on International Trade Law of the International Law Association on the subject of parallel importation
resolves10.1093/jiel/1.4.637
The conflicts between parallel trade and product access and innovation: the case of pharmaceuticals
resolves10.3386/w11288
Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness
resolves10.1177/030981680207600112
Intellectual Property Rights, the WTO and Developing Countries: The TRIPS Agreement and Policy Options
resolves10.1377/hlthaff.w3.521
Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries
resolves10.1023/A:1025384819575
Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents
resolves10.1016/s0167-6296(02)00126-1
The price of innovation: new estimates of drug development costs
resolves10.1111/1467-9701.00382
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal
resolves10.4324/9781315254227-25
TRIPS, Pharmaceutical Patents, and Access to Essential Medicines: A Long Way From Seattle to Doha
resolves10.1016/s0022-2836(02)00427-8
A Revolutionary Landscape: the Restructuring of Biology and its Convergence with Medicine
resolves10.1016/s0277-9536(98)00134-8
Pharmacies, self-medication and pharmaceutical marketing in Bombay, India
resolves10.2471/blt.06.029835
Choosing the right incentive strategy for research and development in neglected diseases
resolves10.1016/s0140-6736(04)16728-7
“Neglected” diseases but unrecognised successes—challenges and opportunities for infectious disease control
resolves10.1038/sj.embor.embor851
Neglected diseases: under‐funded research and inadequate health interventions
resolves10.1038/nrd1230
Virtual drug discovery and development for neglected diseases through public–private partnerships
resolves10.1080/00324728.1975.10410201
The Changing Relation between Mortality and level of Economic Development
resolves10.1016/s1471-4922(02)02387-5
Strategic emphases for tropical diseases research: a TDR perspective
resolves10.1590/s1020-49892002000800017
Macroeconomics and health: investing in health for economic development
resolves10.1046/j.1365-3156.1999.00497.x
Strategies to enhance the use of health systems research for health sector reform
resolves10.1093/jiel/5.4.913
Post-TRIPS Options for Access to Patented Medicines in Developing Nations
resolves10.1016/s0140-6736(02)09096-7
Drug development for neglected diseases: a deficient market and a public-health policy failure
resolves10.2458/azu_acku_pamphlet_ra395_a534_r47_1998
Report of health planning workshop (Kabul, 15 February-2 March, 1998) / World Health Organization (WHO).
resolves10.1016/s0968-8080(02)00085-x
WHO/CONRAD Technical Consultation on Nonoxynol-9, World Health Organization, Geneva, 9–10 October 2001: Summary Report
The 32 references without a DOI — listed, not checked
no DOI — not checkedGenomics and World Health
no DOI — not checkedref5
no DOI — not checkedref10
no DOI — not checkedDeveloping a NeedsBased and Rational Approach to Identify Neglected Diseases and Select R&D Projects that Could Maximally Impact Treatment Options
no DOI — not checkedref15
no DOI — not checkedref16
no DOI — not checkedHow Do The Social Bene?ts and Costs of The Patent System Stack Up in Pharmaceuticals?
no DOI — not checkedref21
no DOI — not checkedref23
no DOI — not checkedref25
no DOI — not checkedBuilding Local Research and Development Capacity for the Prevention and Cure of Neglected Diseases: The Case of India
no DOI — not checkedref31
no DOI — not checkedref41
no DOI — not checkedref53
no DOI — not checkedIncentives and Institutions in the Provision of Health Care in Developing Countries: Toward E� cient and Equitable Health Care Strategy
no DOI — not checkedGive Prizes Not Patents
no DOI — not checkedAvailable online at www
no DOI — not checkedAvailable online at www
no DOI — not checkedref61
no DOI — not checkedref62
no DOI — not checkedref66
no DOI — not checkedUNDP -United Nations Development Programme
no DOI — not checkedref68
no DOI — not checkedref69
no DOI — not checkedGlobal Tuberculosis Control
no DOI — not checkedTuberculosis Disease Information
no DOI — not checkedUNAIDS HIV Vaccine Initiative in
no DOI — not checkedBulletin of the World Health Organization 85
no DOI — not checkedWTO Technical Note
no DOI — not checkedref80
no DOI — not checkedref81
no DOI — not checkedA Comparison of Alternative Policies to Promote health in Developing Economies
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-08-27 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.1138347"><img src="https://citestamp.com/citestamped/10.2139/ssrn.1138347/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.1138347)